266 related articles for article (PubMed ID: 28139534)
61. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
[TBL] [Abstract][Full Text] [Related]
62. p53 exon 4 (codon 72) polymorphism and exon 7 (codon 249) mutation in breast cancer patients in southern region (Madurai) of Tamil Nadu.
Vijayaraman KP; Veluchamy M; Murugesan P; Shanmugiah KP; Kasi PD
Asian Pac J Cancer Prev; 2012; 13(2):511-6. PubMed ID: 22524816
[TBL] [Abstract][Full Text] [Related]
63. Correlation p53 expression and human papilloma virus deoxyribonucleic acid with clinical outcome in early uterine cervical carcinoma.
Ikuta A; Saito J; Mizokami T; Nakamoto T; Yasuhara M; Nagata F; Nakajima M; Matsuo I; Yasuda K; Kanzaki H
Cancer Detect Prev; 2005; 29(6):528-36. PubMed ID: 16289387
[TBL] [Abstract][Full Text] [Related]
64. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
[TBL] [Abstract][Full Text] [Related]
65. Association of P53 codon 72 polymorphism and ameloblastoma.
Kitkumthorn N; Yanatatsaneejit P; Rabalert J; Dhammawipark C; Mutirangura A
Oral Dis; 2010 Oct; 16(7):631-5. PubMed ID: 20412452
[TBL] [Abstract][Full Text] [Related]
66. The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project.
Pastor-Idoate S; Rodriguez-Hernández I; Rojas J; Fernández I; García-Gutierrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon Y; Harsum S; MacLaren RE; Charteris D; van Meurs J; González-Sarmiento R; Pastor JC;
Ophthalmology; 2013 Mar; 120(3):623-628. PubMed ID: 23207172
[TBL] [Abstract][Full Text] [Related]
67. Association of p53 codon 248 (exon7) with urinary bladder cancer risk in the North Indian population.
Jaiswal PK; Goel A; Mittal RD
Biosci Trends; 2011; 5(5):205-10. PubMed ID: 22101376
[TBL] [Abstract][Full Text] [Related]
68. TP53 codon 72 polymorphism and risk of cervical carcinoma in Serbian women.
Malisic E; Jankovic R; Brotto K; Radulovic S
Arch Gynecol Obstet; 2013 Sep; 288(3):621-5. PubMed ID: 23483183
[TBL] [Abstract][Full Text] [Related]
69. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
[TBL] [Abstract][Full Text] [Related]
70. Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism.
Tachezy R; Mikysková I; Saláková M; Van Ranst M
Hum Genet; 1999 Dec; 105(6):564-6. PubMed ID: 10647890
[TBL] [Abstract][Full Text] [Related]
71. p53 codon 72 polymorphism and the risk of lung cancer in a Korean population.
Piao JM; Kim HN; Song HR; Kweon SS; Choi JS; Yun WJ; Kim YC; Oh IJ; Kim KS; Shin MH
Lung Cancer; 2011 Sep; 73(3):264-7. PubMed ID: 21316118
[TBL] [Abstract][Full Text] [Related]
72. Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers.
Wu WJ; Kakehi Y; Habuchi T; Kinoshita H; Ogawa O; Terachi T; Huang CH; Chiang CP; Yoshida O
Jpn J Cancer Res; 1995 Aug; 86(8):730-6. PubMed ID: 7559095
[TBL] [Abstract][Full Text] [Related]
73. Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habits.
Pandima Devi K; Sivamaruthi B; Kiruthiga PV; Karutha Pandian S
Hum Exp Toxicol; 2010 Jun; 29(6):451-8. PubMed ID: 19948747
[TBL] [Abstract][Full Text] [Related]
74. Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer.
Han JY; Lee GK; Jang DH; Lee SY; Lee JS
Cancer; 2008 Aug; 113(4):799-807. PubMed ID: 18618574
[TBL] [Abstract][Full Text] [Related]
75. p53 polymorphism at codon 72--does it constitute a risk for squamous intraepithelial lesions and invasive cancer of the cervix in Central Europeans?
Kucera E; Tong D; Reinthaller A; Leodolter S; Zeillinger R; Sliutz G
Wien Klin Wochenschr; 2000 Sep; 112(18):817-20. PubMed ID: 11072671
[TBL] [Abstract][Full Text] [Related]
76. P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population.
Shen H; Solari A; Wang X; Zhang Z; Xu Y; Wang L; Hu X; Guo J; Wei Q
Oncol Rep; 2004 May; 11(5):1115-20. PubMed ID: 15069555
[TBL] [Abstract][Full Text] [Related]
77. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women.
Agorastos T; Lambropoulos AF; Constantinidis TC; Kotsis A; Bontis JN
Eur J Cancer Prev; 2000 Apr; 9(2):113-8. PubMed ID: 10830578
[TBL] [Abstract][Full Text] [Related]
78. Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment.
Shen CC; Cheng WY; Lee CH; Dai XJ; Chiao MT; Liang YJ; Hsieh WY; Mao TF; Lin GS; Chen SR; Liu BS; Chen JP
BMC Cancer; 2020 Jul; 20(1):709. PubMed ID: 32727419
[TBL] [Abstract][Full Text] [Related]
79. Genetic polymorphism of p53 and XRCC1 in cervical intraepithelial neoplasm in Taiwanese women.
Wu MT; Liu CL; Ho CK; Wu TN
J Formos Med Assoc; 2004 May; 103(5):337-43. PubMed ID: 15216398
[TBL] [Abstract][Full Text] [Related]
80. P53 codon 72 polymorphism in bladder cancer--no evidence of association with increased risk or invasiveness.
Törüner GA; Uçar A; Tez M; Cetinkaya M; Ozen H; Ozçelik T
Urol Res; 2001 Dec; 29(6):393-5. PubMed ID: 11828992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
